Table of Content

1. Executive Summary
1.1. Global Pain Relief Patches Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overviews
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Drug Adoption Analysis
3.2. Value Chain Analysis
3.2.1. List of End-user/Marketplaces
3.2.1.1. Retail
3.2.1.2. E-commerce
3.2.2. List of Indication (Industry)
3.3. Key Deals and Mergers
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Global Pain Relief Patches Market Outlook
4.1. Key Highlights
4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
4.3. Global Pain Relief Patches Market Outlook: Product Type
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 – 2023
4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
4.3.3.1. Non-steroidal Anti-inflammatory Drug Patches
4.3.3.1.1. Ketoprofen Patches
4.3.3.1.2. Diclofenac Patches
4.3.3.1.3. Flurbiprofen Patches
4.3.3.1.4. Piroxicam Patches
4.3.3.2. Opioid Patches
4.3.3.2.1. Fentanyl Patches
4.3.3.2.2. Buprenorphine Patches
4.3.3.3. Local Anesthetic Patches
4.3.3.3.1. Nitroglycerine Patches
4.3.3.3.2. Capsaicin Patches
4.3.3.3.3. Lidocaine Patches
4.3.4. Market Attractiveness Analysis: Product Type
4.4. Global Pain Relief Patches Market Outlook: Indication
4.4.1. Introduction / Key Findings
4.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 – 2023
4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
4.4.3.1. Menstrual Cramps
4.4.3.2. Orthopedic Pain
4.4.3.3. Neuropathic Pain
4.4.3.4. Post-operative Pain
4.4.3.5. Cardiovascular Pain
4.4.3.6. Others
4.4.4. Market Attractiveness Analysis: Indication
4.5. Global Pain Relief Patches Market Outlook: Distribution Channel
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 – 2023
4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
4.5.3.1. Hospital Pharmacies
4.5.3.2. Retail Pharmacies
4.5.3.3. Online Pharmacies
4.5.4. Market Attractiveness Analysis: Distribution Channel
5. Global Pain Relief Patches Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 – 2023
5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 – 2032
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Pain Relief Patches Market Outlook
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
6.2.1. By Country
6.2.2. By Product Type
6.2.3. By Indication
6.2.4. By Distribution Channel
6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
6.4.1. Permanent
6.4.2. Contract Basis
6.5. Market Attractiveness Analysis
7. Europe Pain Relief Patches Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
7.2.1. By Country
7.2.2. By Product Type
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
7.4.1. Non-steroidal Anti-inflammatory Drug Patches
7.4.1.1. Ketoprofen Patches
7.4.1.2. Diclofenac Patches
7.4.1.3. Flurbiprofen Patches
7.4.1.4. Piroxicam Patches
7.4.2. Opioid Patches
7.4.2.1. Fentanyl Patches
7.4.2.2. Buprenorphine Patches
7.4.3. Local Anesthetic Patches
7.4.3.1. Nitroglycerine Patches
7.4.3.2. Capsaicin Patches
7.4.3.3. Lidocaine Patches
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
7.5.1. Menstrual Cramps
7.5.2. Orthopedic Pain
7.5.3. Neuropathic Pain
7.5.4. Post-operative Pain
7.5.5. Cardiovascular Pain
7.5.6. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Online Pharmacies
7.7. Market Attractiveness Analysis
8. East Asia Pain Relief Patches Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Indication
8.2.4. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
8.4.1. Non-steroidal Anti-inflammatory Drug Patches
8.4.1.1. Ketoprofen Patches
8.4.1.2. Diclofenac Patches
8.4.1.3. Flurbiprofen Patches
8.4.1.4. Piroxicam Patches
8.4.2. Opioid Patches
8.4.2.1. Fentanyl Patches
8.4.2.2. Buprenorphine Patches
8.4.3. Local Anesthetic Patches
8.4.3.1. Nitroglycerine Patches
8.4.3.2. Capsaicin Patches
8.4.3.3. Lidocaine Patches
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
8.5.1. Menstrual Cramps
8.5.2. Orthopedic Pain
8.5.3. Neuropathic Pain
8.5.4. Post-operative Pain
8.5.5. Cardiovascular Pain
8.5.6. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. Online Pharmacies
8.7. Market Attractiveness Analysis
9. South Asia and Oceania Pain Relief Patches Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Indication
9.2.4. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
9.4.1. Non-steroidal Anti-inflammatory Drug Patches
9.4.1.1. Ketoprofen Patches
9.4.1.2. Diclofenac Patches
9.4.1.3. Flurbiprofen Patches
9.4.1.4. Piroxicam Patches
9.4.2. Opioid Patches
9.4.2.1. Fentanyl Patches
9.4.2.2. Buprenorphine Patches
9.4.3. Local Anesthetic Patches
9.4.3.1. Nitroglycerine Patches
9.4.3.2. Capsaicin Patches
9.4.3.3. Lidocaine Patches
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
9.5.1. Menstrual Cramps
9.5.2. Orthopedic Pain
9.5.3. Neuropathic Pain
9.5.4. Post-operative Pain
9.5.5. Cardiovascular Pain
9.5.6. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. Online Pharmacies
9.7. Market Attractiveness Analysis
10. Latin America Pain Relief Patches Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Indication
10.2.4. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
10.4.1. Non-steroidal Anti-inflammatory Drug Patches
10.4.1.1. Ketoprofen Patches
10.4.1.2. Diclofenac Patches
10.4.1.3. Flurbiprofen Patches
10.4.1.4. Piroxicam Patches
10.4.2. Opioid Patches
10.4.2.1. Fentanyl Patches
10.4.2.2. Buprenorphine Patches
10.4.3. Local Anesthetic Patches
10.4.3.1. Nitroglycerine Patches
10.4.3.2. Capsaicin Patches
10.4.3.3. Lidocaine Patches
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
10.5.1. Menstrual Cramps
10.5.2. Orthopedic Pain
10.5.3. Neuropathic Pain
10.5.4. Post-operative Pain
10.5.5. Cardiovascular Pain
10.5.6. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. Online Pharmacies
10.7. Market Attractiveness Analysis
11. Middle East & Africa Pain Relief Patches Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 – 2023
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Indication
11.2.4. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 – 2032
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025 – 2032
11.4.1. Non-steroidal Anti-inflammatory Drug Patches
11.4.1.1. Ketoprofen Patches
11.4.1.2. Diclofenac Patches
11.4.1.3. Flurbiprofen Patches
11.4.1.4. Piroxicam Patches
11.4.2. Opioid Patches
11.4.2.1. Fentanyl Patches
11.4.2.2. Buprenorphine Patches
11.4.3. Local Anesthetic Patches
11.4.3.1. Nitroglycerine Patches
11.4.3.2. Capsaicin Patches
11.4.3.3. Lidocaine Patches
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 – 2032
11.5.1. Menstrual Cramps
11.5.2. Orthopedic Pain
11.5.3. Neuropathic Pain
11.5.4. Post-operative Pain
11.5.5. Cardiovascular Pain
11.5.6. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 – 2032
11.6.1. Hospital Pharmacies
11.6.2. Retail Pharmacies
11.6.3. Online Pharmacies
11.7. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2025
12.2. Market Structure
12.2.1. Competition Intensity Mapping by Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
12.3.1. Viatris, Inc. (Mylan)
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. Johnson & Johnson Services, Inc.
12.3.3. Teva Pharmaceutical Industries Ltd.
12.3.4. Sanofi S.A.
12.3.5. Hisamitsu Pharmaceutical Co., Inc.
12.3.6. GlaxoSmithKline Plc.
12.3.7. Novartis AG
12.3.8. Nichiban Co., Ltd.
12.3.9. Teikoku Seiyaku Co, Ltd.
12.3.10. Mentholatum Company
12.3.11. Purdue Pharma L.P.
12.3.12. West-Ward Pharmaceuticals Corporation
12.3.13. Pfizer, Inc
12.3.14. Allergan PLC (Actavis)
12.3.15. Endo International PLC
12.3.16. Mylan N.V.
12.3.17. Corium, Inc.
12.3.18. Agile Therapeutics Inc.
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations